Spinal Muscular Atrophy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with a spine condition:
- You have been diagnosed with Ankylosing Spondylitis or a related spine condition called non-radiographic Spondyloarthritis, confirmed using standard medical criteria
- You are between 18 and 65 years old
- You are willing to give your consent to take part in the study
For healthy volunteers:
- You are a healthy person between 18 and 65 years old who can be matched by age and gender to a patient participant
- You are willing to give your consent to take part in the study
Who may not be able to join:
- You have been taking high-dose steroid medication (more than 5mg of prednisone per day for more than 3 months)
- You have certain other health conditions that can cause muscle loss, such as uncontrolled diabetes, chronic heart failure, thyroid or parathyroid disease, chronic kidney failure, or chronic liver failure
- You have a hand condition or injury that would affect your ability to have your grip strength measured accurately
- You are taking certain medications that can affect bone health, such as bisphosphonates, teriparatide, anticonvulsants, heparin, or blood thinners
- You have psoriasis or inflammatory bowel disease
- You have an active infection in the thigh area where an ultrasound scan would be carried out
- You weigh more than 100 kg, as this affects the bone density scanning equipment used in the study
- You are assessed as malnourished based on a short nutrition screening questionnaire (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ayşe A Küçükdeveci, MD, Ankara University, Medical Faculty
Phone: +90 312 5082850
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Presence of osteosarcopenia
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.